# ARKG holdings and overlap

ARKG holds 32 positions in its SEC Form N-PORT for the period ended 2026-07-31, filed 2026-09-22. Its three largest are 10x Genomics (TXG) at 9.39%, Twist Bioscience (TWST) at 7.73% and Tempus AI (TEM) at 6.56%, and its ten largest make up 59.1% of the fund.

ARK Genomic Revolution ETF, Health Care, ARK Invest.

Canonical page: https://tickerinside.com/etf/arkg/
Holdings from ARKG's SEC Form N-PORT for the period ended 2026-07-31, filed 2026-09-22.
Licence: CC BY 4.0, attribution to TickerInside. Measurements, not investment advice.

## Largest positions, SEC Form N-PORT for the period ended 2026-07-31

| Rank | Ticker | Company | Weight |
| --- | --- | --- | --- |
| 1 | TXG | 10x Genomics | 9.39% |
| 2 | TWST | Twist Bioscience | 7.73% |
| 3 | TEM | Tempus AI | 6.56% |
| 4 | CRSP | CRISPR Therapeutics AG | 6.29% |
| 5 | PSNL | Personalis | 5.47% |
| 6 | ABSI | Absci | 5.14% |
| 7 | GH | Guardant Health | 4.74% |
| 8 | [ILMN](https://tickerinside.com/stock/ilmn/) | Illumina | 4.74% |
| 9 | [LLY](https://tickerinside.com/stock/lly/) | Eli Lilly | 4.68% |
| 10 | CDNA | CareDx | 4.3% |
| 11 | NTRA | Natera | 4.13% |
| 12 | BEAM | Beam Therapeutics | 3.78% |
| 13 | CMPS | COMPASS Pathways Plc | 3.25% |
| 14 | RXRX | Recursion Pharmaceuticals | 2.63% |
| 15 | ADPT | Adaptive Biotechnologies | 2.57% |
| 16 | VCYT | Veracyte | 2.55% |
| 17 | NRIX | Nurix Therapeutics | 2.51% |
| 18 | BFLY | Butterfly Network | 2.18% |
| 19 | SDGR | Schrodinger | 1.99% |
| 20 | WGS | GeneDx | 1.87% |
| 21 | NTLA | Intellia Therapeutics | 1.83% |
| 22 | IONS | Ionis Pharmaceuticals | 1.77% |
| 23 | ALMR | Alamar Biosciences Inc. | 1.56% |
| 24 | PRME | Prime Medicine | 1.41% |
| 25 | GENB | Generate Biomedicines Inc. | 1.11% |

All 32 positions with weights: https://tickerinside.com/api/v1/fund/arkg.json

Category: Health Care, set by TickerInside from the ETF's own latest file. In its file of 2026-07-31, 100% of its stocks whose sector is known are health care companies, each in the sector the site gives that company. How categories are set: https://tickerinside.com/etf/category/

## How is ARKG split by sector?

In its SEC Form N-PORT for the period ended 2026-07-31, filed 2026-09-22, ARKG is 99.6% health care by sector, with none of it in mega-cap tech or in the ten largest US companies by market value.

| Sector | Weight |
| --- | --- |
| Health care | 99.6% |

How these are measured: https://tickerinside.com/how-the-numbers-are-produced/#sectors


## What did ARKG hold in its SEC reports since 2020?

In ARKG's SEC filings, its largest position went from Illumina, Inc. (ILMN) at 8.97% on 2020-04-30 to 10x Genomics, Inc. (TXG) at 9.39% on 2026-07-31, across 26 quarterly reports.

| Report for | Positions | Largest position | Ten largest |
| --- | --- | --- | --- |
| 2020-04-30 | 36 | ILMN 8.97% | 61.6% |
| 2020-10-30 | 46 | NVTA 8.85% | 52.8% |
| 2021-10-29 | 51 | TDOC 8.94% | 43.7% |
| 2022-10-31 | 46 | EXAS 6.90% | 46.4% |
| 2023-10-31 | 39 | EXAS 10.73% | 51.0% |
| 2024-10-31 | 37 | TWST 8.35% | 52.6% |
| 2025-10-31 | 35 | TEM 10.18% | 55.3% |
| 2026-07-31 | 32 | TXG 9.39% | 59.0% |

The first report, then the last of each year, of the 26 reports ARKG filed on SEC Form N-PORT from 2020-04-30 to 2026-07-31; companies are keyed by their ticker today. Every position of every report: https://tickerinside.com/api/v1/quarterly/arkg.json; at any date: https://tickerinside.com/api/v1/history/arkg/{date}.json. How these are read: https://tickerinside.com/how-the-numbers-are-produced/#sec-history
## Key figures

| Measure | Value |
| --- | --- |
| Expense ratio, SEC filing 2025-11-26 | 0.75% |
| Positions, N-PORT 2026-07-31 | 32 |
| Weight in the ten largest, N-PORT 2026-07-31 | 59.1% |

## What does ARKG share with other ETFs?

| ETF | Overlap by weight | Of ARKG held there | Of that ETF in ARKG | Companies in both |
| --- | --- | --- | --- | --- |
| ARKK | 27.7% | 58.3% | 28.7% | 14 |
| PTH | 21.1% | 42.8% | 21.2% | 8 |
| PBE | 11.4% | 11.5% | 15.1% | 3 |
| XBI | 11.3% | 44.2% | 11.3% | 12 |
| IBB | 11.3% | 78.6% | 11.3% | 21 |
| IDNA | 9.5% | 23.8% | 9.5% | 6 |
| IBBQ | 8.8% | 74.9% | 8.8% | 20 |
| QQQJ | 7.0% | 22.0% | 7.0% | 5 |
| VHT | 6.8% | 81.2% | 14.9% | 25 |
| IYH | 6.7% | 26.7% | 16.7% | 6 |
| XLV | 5.4% | 9.5% | 15.8% | 2 |
| IXJ | 5.2% | 9.5% | 11.1% | 2 |


The holdings of ARKG and ARKK are from their SEC Form N-PORT filings for the period ended 2026-07-31, filed 2026-09-22. The other ETFs' holdings are from their issuers' latest files.

Method: https://tickerinside.com/how-the-numbers-are-produced/

## Cite this page

TickerInside, ARK Genomic Revolution ETF (ARKG), holdings from SEC Form N-PORT for the period ended 2026-07-31, filed 2026-09-22, https://tickerinside.com/etf/arkg/, CC BY 4.0

    <a href="https://tickerinside.com/etf/arkg/">TickerInside</a> (https://tickerinside.com/etf/arkg/)